Jason M. Aryeh
Independent DirectorMr. Jason M. Aryeh is Director of Lifecore Biomedical, Inc. from August 15, 2024. Mr. Aryeh serves as an Independent Director at Orchestra BioMed Holdings, Inc. since January 2023 and had been Independent Director of Health Sciences Acquisitions Corporation 2 (formerly known as Orchestra BioMed, Inc.) since November 2018 until January 2023. He has been an Independent Director of Anebulo Pharmaceuticals, Inc. since March 2021. Mr. Aryeh is the Founder and Managing General Partner of JALAA Equities, LLP and served as its General Partner since 1997. Mr. Aryeh co-founded Rio Grande Renewables, LLC in 2009 and serves as its Chairman of the Board and chairman of Rio Grande Solar. Mr. Aryeh is active in a respected healthcare charity, serving as both a Special Advisor to the Cystic Fibrosis Foundation Therapeutics Inc. for Drug Discovery and as Honorary Chairman of the New Mexico Chapter of the CFF. Mr. Aryeh serves as a consultant of Derma Sciences, Inc. He has of equity investment experience focused on the life sciences industry. He was Independent Director of Novelion Therapeutics Inc. from June 4, 2012 to August 9, 2018 and served as its Chairman of the Board from November 2016 to July 3, 2018. He has been the Chairman of QLT at QLT Ophthalmics, Inc. since July 2012. He serves as a Director of Orchestra BioMed. He has been an Independent Director of Ligand Pharmaceuticals Incorporated since September 2006. He serves as Director of Cytovia Therapeutics, Inc since May 13, 2021. He served as the Chairman of Immunomedics, Inc. since June 30, 2017. He served as Vice Chairman at Immunomedics, Inc. from January 9, 2017 from June 30, 2017. He served as a Lead Independent Director of Cormatrix Cardiovascular, Inc. and also served as its Director from 2010 to March 9, 2017. He served as a Director of Aralez Pharmaceuticals Inc. from February 5, 2016 to June 7, 2017. He served as a Director of Myrexis, Inc. until January 23, 2013. He served as an Independent Director of Nabi Biopharmaceuticals Inc. from November 13, 2006 to November 8, 2012. He is a Member of Omnicron Delta Epsilon Honor Society in Economics and was Director of the Cystic Fibrosis Foundation Therapeutics Inc since February 2011 to February 2018. Mr. Aryeh serves as a Director at Cytovia, Inc. He is a member of the Omicron Delta Epsilon Society in economics. He has a BA in Economics from Colgate University.
Positions
- Company NameAnebulo Pharmaceuticals, Inc.Stock CodeANEBPositionIndependent Director
- Company NameLigand Pharmaceuticals IncorporatedStock CodeLGNDPositionIndependent DirectorColleagues
- TCTodd C. DavisCEO & Director
- JWJohn Warren KozarichIndependent Chairman
- OEOctavio EspinozaChief Financial Officer
- ATAndrew T. ReardonChief Legal Officer & Secretary
- PJPaul J. HaddenSenior Vice President of Investments & Business Development
- MJMelanie J. HermanExecutive Director of Investor Relations and Financial Planning & Analysis
- SLStephen Lawrence SabbaIndependent Director
- JHJason HaasIndependent Director
- Company NameOrchestra BioMed Holdings, Inc.Stock CodeOBIOPositionIndependent DirectorColleagues
- DPDavid P. HochmanFounder, Chairman of the Board of Directors & CEO
- DRDarren R. ShermanFounder, President, COO & Director
- ALAndrew Lawrence TaylorChief Financial Officer
- WRWilliam Reed LittleExecutive Vice President of Corporate Development & Strategy
- LDLisa DanielsVice President of Human Resources
- ESEric S. FainIndependent Lead Director
- JMJason M. AryehIndependent Director
- PYPamela Yanchik ConnealyIndependent Director
